Ko‐Jiunn Liu

3.0k total citations · 1 hit paper
65 papers, 2.4k citations indexed

About

Ko‐Jiunn Liu is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Ko‐Jiunn Liu has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Immunology and 18 papers in Genetics. Recurrent topics in Ko‐Jiunn Liu's work include Mesenchymal stem cell research (17 papers), Immunotherapy and Immune Responses (14 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Ko‐Jiunn Liu is often cited by papers focused on Mesenchymal stem cell research (17 papers), Immunotherapy and Immune Responses (14 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Ko‐Jiunn Liu collaborates with scholars based in Taiwan, United States and China. Ko‐Jiunn Liu's co-authors include B. Linju Yen, Huey‐Kang Sytwu, Ming‐Shyen Yen, Li‐Tzu Wang, Kenneth K. Wu, Neng‐Yao Shih, Peimin Chen, Jang‐Yang Chang, Chyi‐Huey Bai and Ching‐Chuan Kuo and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ko‐Jiunn Liu

64 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials

2016 267 citations Li‐Tzu Wang, Ming‐Shyen Yen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ko‐Jiunn Liu Taiwan	26	1.0k	663	549	473	371	65	2.4k
Hussein Fayyad‐Kazan Lebanon	26	1.1k 1.1×	860 1.3×	584 1.1×	341 0.7×	888 2.4×	93	2.7k
Bhavana J. Davé United States	29	1.1k 1.1×	509 0.8×	693 1.3×	1.0k 2.2×	549 1.5×	98	3.3k
Fengjun Xiao China	30	1.6k 1.5×	437 0.7×	344 0.6×	437 0.9×	817 2.2×	101	2.7k
José C. Segovia Spain	32	1.5k 1.5×	490 0.7×	368 0.7×	572 1.2×	262 0.7×	120	3.3k
Mitsugu Fujita Japan	29	1.2k 1.1×	493 0.7×	1.3k 2.3×	1000 2.1×	445 1.2×	114	3.2k
Mehryar Habibi Roudkenar Iran	30	1.3k 1.3×	649 1.0×	252 0.5×	204 0.4×	473 1.3×	147	2.9k
Clara Bueno Spain	38	1.9k 1.8×	546 0.8×	676 1.2×	588 1.2×	199 0.5×	106	3.4k
Yen‐Hua Huang Taiwan	26	957 1.0×	258 0.4×	273 0.5×	346 0.7×	377 1.0×	57	2.2k
Sherif Ibrahim Egypt	28	1.4k 1.4×	438 0.7×	610 1.1×	695 1.5×	619 1.7×	107	3.2k

Countries citing papers authored by Ko‐Jiunn Liu

Since Specialization

Citations

This map shows the geographic impact of Ko‐Jiunn Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko‐Jiunn Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko‐Jiunn Liu more than expected).

Fields of papers citing papers by Ko‐Jiunn Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko‐Jiunn Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko‐Jiunn Liu. The network helps show where Ko‐Jiunn Liu may publish in the future.

Co-authorship network of co-authors of Ko‐Jiunn Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ko‐Jiunn Liu. A scholar is included among the top collaborators of Ko‐Jiunn Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko‐Jiunn Liu. Ko‐Jiunn Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Wei‐Min, Chia-Yu Wu, Hsin‐Lun Lee, et al.. (2025). EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis. Neoplasia. 66. 101193–101193. 1 indexed citations

Yang, Yi‐Yuan, Sy‐Jye Leu, Ko‐Jiunn Liu, et al.. (2024). Characterization of chicken-derived antibody against Alpha-Enolase of Streptococcus pneumoniae. International Immunopharmacology. 128. 111476–111476. 5 indexed citations

Tseng, Jen‐Chih, Jingxing Yang, Chia‐Yin Lee, et al.. (2023). Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug. International Journal of Biological Sciences. 19(9). 2648–2662. 4 indexed citations

Leu, Sy‐Jye, et al.. (2023). Generation and characterization of avian single chain variable fragment against human Alpha-Enolase. International Immunopharmacology. 120. 110277–110277. 1 indexed citations

Wang, Li‐Tzu, B. Linju Yen, Ying-Yin Chao, et al.. (2022). Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1β in Klebsiella-mediated acute respiratory distress syndrome. Thorax. 78(5). 504–514. 14 indexed citations

Yen, B. Linju, Ko‐Jiunn Liu, Huey‐Kang Sytwu, & Ming‐Shyen Yen. (2022). Clinical implications of differential functional capacity between tissue‐specific human mesenchymal stromal/stem cells. FEBS Journal. 290(11). 2833–2844. 13 indexed citations

Tseng, Jen‐Chih, Jingxing Yang, Yiling Liu, et al.. (2021). Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide. Cancer Immunology Immunotherapy. 71(5). 1115–1128. 12 indexed citations

Dai, Hong-Jie, Yu‐Cheng Chang, Chih–Jen Huang, et al.. (2020). Cancer Registry Information Extraction via Transfer Learning. 201–208.

Lee, Chia‐Huei, Ko‐Jiunn Liu, Kai‐Cheng Hsu, et al.. (2020). LDOC1 Suppresses Microbe-Induced Production of IL-1β in Human Normal and Cancerous Oral Cells through the PI3K/Akt/GSK-3β Axis. Cancers. 12(11). 3148–3148. 10 indexed citations

10.

Wang, Chih‐Liang, Yi‐Cheng Wu, Ko‐Jiunn Liu, et al.. (2020). Integrative Omics Analysis Reveals Soluble Cadherin-3 as a Survival Predictor and an Early Monitoring Marker of EGFR Tyrosine Kinase Inhibitor Therapy in Lung Cancer. Clinical Cancer Research. 26(13). 3220–3229. 19 indexed citations

11.

Wang, Li‐Tzu, Li-Yueh Huang, Sheng-Kang Chiu, et al.. (2020). Human Placental MSC-Secreted IL-1β Enhances Neutrophil Bactericidal Functions during Hypervirulent Klebsiella Infection. Cell Reports. 32(13). 108188–108188. 23 indexed citations

12.

Wang, Wei‐Bei, Ming‐Shyen Yen, Ko‐Jiunn Liu, et al.. (2015). Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses. Stem Cell Reports. 5(3). 392–404. 66 indexed citations

13.

Lee, Chia‐Huei, Jeffrey S. Chang, Thian‐Sze Wong, et al.. (2014). IL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer. Journal of Cellular Physiology. 230(4). 875–884. 168 indexed citations

14.

Yen, B. Linju, et al.. (2013). Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-Derived Suppressor Cells via Hepatocyte Growth Factor/c-Met and STAT3. Stem Cell Reports. 1(2). 139–151. 120 indexed citations

15.

Hua, Tzu-En, et al.. (2013). 3-D neurohistology of transparent tongue in health and injury with optical clearing. Frontiers in Neuroanatomy. 7. 36–36. 12 indexed citations

16.

Chu, Ching‐Liang, et al.. (2012). The Immunomodulatory Activity of Meningococcal Lipoprotein Ag473 Depends on the Conformation Made up of the Lipid and Protein Moieties. PLoS ONE. 7(7). e40873–e40873. 10 indexed citations

17.

Lin, Chi‐Chen, et al.. (2011). A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunology Immunotherapy. 60(7). 1019–1027. 54 indexed citations

18.

Chang, Gee‐Chen, Ko‐Jiunn Liu, Chia‐Ling Hsieh, et al.. (2006). Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes. Clinical Cancer Research. 12(19). 5746–5754. 128 indexed citations

19.

Juang, Shin‐Hun, Sung‐Jen Wei, Yi‐Mei Hung, et al.. (2004). IFN-β Induces Caspase-Mediated Apoptosis by Disrupting Mitochondria in Human Advanced Stage Colon Cancer Cell Lines. Journal of Interferon & Cytokine Research. 24(4). 231–243. 32 indexed citations

20.

Liu, Ko‐Jiunn, et al.. (2004). Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme. International Journal of Oncology. 24(3). 581–90. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact